Affiliation:
1. Xicheng District Guangwai Hospital, China
2. University of Medicine and Health Sciences, China
3. Academician of the World Academy of Productivity Sciences, China
Abstract
Abstract Background Cardiovascular disease (CVD) is a series of diseases affecting the heart or blood vessels. Objectives To assess the relationship between blood pressure (BP) levels defined by the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline and CVD/atherosclerotic cardiovascular disease (ASCVD) risk for middle-aged and elderly people in China. Methods A total of 6,644 middle-aged and elderly people from the China Health and Retirement Longitudinal Study (CHARLS) were finally included. According to the 2017 ACC/AHA guideline, all subjects were divided into four groups: normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension. The outcome of this study was considered as the risk of CVD and ASCVD. Univariate and multivariate COX regression models were adopted to examine the relationship of the 2017 ACC/AHA BP classification with the risk of CVD. Univariate and multivariate logistic regression models were used to investigate the association between BP levels and ASCVD risk. Subgroup analyses based on age, gender, and use of antihypertensive drugs were performed. P<0.05 was accepted as statistically significant. Results After adjusting all covariates, compared to middle-aged and elderly patients with normal BP, we found that patients with stage 1/2 hypertension were associated with a higher risk of CVD, separately. Simultaneously, we also observed a positive association between individuals with elevated BP, stage 1 hypertension, stage 2 hypertension, and higher ASCVD risk in the fully adjusted model. The result of subgroup analyses implied that the relationship between stage 1/2 hypertension and CVD/ high ASCVD was robust in different ages and genders, and participants without using antihypertensive drugs. Conclusion BP classification under the 2017 ACC/AHA BP guidelines may apply to the Chinese population.
Publisher
Sociedade Brasileira de Cardiologia
Reference25 articles.
1. Cardiovascular Disease (CVD): Assessment, Prediction and Policy Implications;Rehman S;BMC Public Health,2021
2. Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study;Liu S;JAMA Cardiol,2019
3. Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International;Du X;J Am Coll Cardiol,2019
4. Study of Cardiovascular Disease Prediction Model Based on Random Forest in Eastern China;Yang L;Sci Rep,2020
5. High Blood Pressure and Cardiovascular Disease;Fuchs FD;Hypertension,2020